Cargando…
Case Report: Active tuberculosis infection in CAR T-cell recipients post CAR T-cell therapy: a retrospective case series
High response rates in B-cell malignancies have been achieved with chimeric antigen receptor (CAR) T-cell therapy. Emerging reports indicate a risk of active tuberculosis (TB) with novel immunotherapy for tumors. However, studies of TB in patients post CAR T-cell therapy are limited. In this case se...
Autores principales: | Zhang, Peiling, Huang, Liang, Zheng, Miao, Zhang, Chao, Wan, Dongyi, Wei, Jia, Cao, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210154/ https://www.ncbi.nlm.nih.gov/pubmed/37249982 http://dx.doi.org/10.3389/fcimb.2023.1147454 |
Ejemplares similares
-
Engineering CAR T Cells to Target the HIV Reservoir
por: Mu, Wenli, et al.
Publicado: (2020) -
Rare tuberculosis in recipients of allogeneic hematopoietic stem cell transplantation successfully treated with contezolid–a typical case report and literature review
por: Li, Junhong, et al.
Publicado: (2023) -
Sars-Cov-2 Infections in CAR T Cell Recipients
por: McNerney, Kevin O., et al.
Publicado: (2021) -
Gut Microbiota Dysbiosis in BK Polyomavirus-Infected Renal Transplant Recipients: A Case-Control Study
por: Zhang, Jian, et al.
Publicado: (2022) -
The Potential Association of Delayed T Lymphocyte Reconstitution Within Six Months Post-Transplantation With the Risk of Cytomegalovirus Retinitis in Severe Aplastic Anemia Recipients
por: Mo, Wenjian, et al.
Publicado: (2022)